Please enable JS

Investors & Media

Past Event Calendar

Upcoming EventsPast Events
CRISPR Therapeutics at Bank of America Merrill Lynch 2018 Health Care Conference
Thursday, May 17, 2018

CRISPR Therapeutics at Deutsche Bank's 43rd Annual Health Care Conference
Wednesday, May 9, 2018

CRISPR Therapeutics at 17th Annual Needham Healthcare Conference
Wednesday, March 28, 2018

CRISPR Therapeutics at Guggenheim Conference on Disruptive Technologies in Immuno-Oncology
Tuesday, March 27, 2018

CRISPR Therapeutics at Barclays Global Healthcare Conference
Tuesday, March 13, 2018

CRISPR Therapeutics at RBC Capital Markets 2018 Healthcare Conference
Thursday, February 22, 2018

CRISPR Therapeutics at Guggenheim 4th Annual Boston Healthcare Conference
Wednesday, December 13, 2017

CRISPR Therapeutics at American Society of Hematology (ASH) Annual Meeting
Sunday, December 10, 2017
Supporting Materials
Download Event Supporting Material 2017 American Society of Hematology Annual Meeting Presentation: CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and ß-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin

CRISPR Therapeutics at Citi 2017 Global Healthcare Conference
Wednesday, December 6, 2017

CRISPR Therapeutics at Barclays Gene Editing & Gene Therapy Summit
Thursday, November 30, 2017

CRISPR Therapeutics at Evercore ISI BioPharma Catalyst/Deep Dive Conference
Thursday, November 30, 2017

CRISPR Therapeutics at 29th Annual Piper Jaffray Healthcare Conference
Wednesday, November 29, 2017

CRISPR Therapeutics SITC Event: Allogeneic CRISPR-based CAR-T Therapy
Friday, November 10, 2017
Supporting Materials
Download Event Supporting Material SITC 2017 Investor Reception Presentation
Download Event Supporting Material Production of Site-specific Allogeneic CAR-T Cells by CRISPR/Cas9 for B-Cell Malignancies

CRISPR Therapeutics at Jefferies Gene Technology Investor Summit
Thursday, October 12, 2017

CRISPR Therapeutics at Chardan Gene Therapy Conference
Tuesday, October 10, 2017

CRISPR Therapeutics at Piper Jaffray GenomeRx Symposium
Tuesday, July 11, 2017

CRISPR Therapeutics at 22nd European Hematology Association Annual Congress
Friday, June 23, 2017
LocationMadridES
Supporting Materials
Download Event Supporting Material 2017 European Hematology Association Annual Congress Presentation

CRISPR Therapeutics at JMP Securities Life Sciences Conference
Tuesday, June 20, 2017
LocationSt. Regis
New York, NY

CRISPR Therapeutics at UBS Global Healthcare Conference
Tuesday, May 23, 2017
Supporting Materials
Download Event Supporting Material UBS Global Healthcare Conference Presentation

CRISPR Therapeutics at Bank of America Merrill Lynch 2017 Health Care Conference
Wednesday, May 17, 2017

CRISPR Therapeutics at 42nd Annual Deutsche Bank Health Care Conference
Wednesday, May 3, 2017
Supporting Materials
Download Event Supporting Material 42nd Annual Deutsche Bank Health Care Conference Presentation

CRISPR Therapeutics at 16th Annual Needham Healthcare Conference
Wednesday, April 5, 2017
Supporting Materials
Download Event Supporting Material 2017 Needham Conference Presentation

CRISPR Therapeutics at Annual Barclays Global Healthcare Conference
Thursday, March 16, 2017

CRISPR Therapeutics to Host Conference Call and Webcast to Provide an Update on the CRISPR/Cas9 U.S. Patent Interference Proceedings and Corresponding U.K. Patents
Thursday, February 16, 2017

CRISPR Therapeutics at 58th American Society of Hematology (ASH) Annual Meeting
Friday, December 16, 2016
Supporting Materials
Download Event Supporting Material CRISPR/Cas9-mediated genome editing of Human CD34+ cells upregulate fetal hemoglobin to clinically relevant levels in single cell-derived erythroid colonies poster presented at the 2016 American Society of Hematology Annual Meeting
Download Event Supporting Material Re-Creating Hereditary Persistence of Fetal Hemoglobin (HPFH) to treat Sickle Cell Disease and ß-thalassemia poster presented at the 2016 American Society of Hematology Annual Meeting
Download Event Supporting Material CRISPR Therapeutics Announces Two Presentations Demonstrating the Potential for CRISPR Gene Editing To Treat Sickle Cell Disease and ß-Thalassemia

CRISPR Therapeutics at the 28th Annual Piper Jaffray Healthcare Conference
Wednesday, November 30, 2016
LocationNew York, NY

CRISPR Therapeutics at Stifel 2016 Healthcare Conference
Tuesday, November 15, 2016

Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet